Drug Trial Radar · NCT05739383
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
14,012
Actual
Start
Mar 9, 2023
Primary completion
Apr 16, 2029
Study completion Apr 16, 2029
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Feb 22, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years, up to 79 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
CKJX839D12302 is a pivotal Phase III study designed to test the hypothesis that treatment with inclisiran sodium 300 milligram (mg) subcutaneous (s.c.) administered on Day 1, Day 90, and every 6 months thereafter in patients at high cardiovascular (CV) risk without a prior major atherosclerotic cardiovascular disease (ASCVD) event will significantly reduce the risk of 4-Point-Major Adverse Cardiovascular Events (4P-MACE) defined as a composite of CV death, non-fatal myocardial infarction (MI), non-fatal ischemic stroke, and urgent coronary revascularization, compared to placebo.
Conditions
- Primary Prevention of Atherosclerotic Cardiovascular Disease
Interventions
Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mLDrug
Subcutaneous injection in pre-filled syringe.
Placebo in 1.5mlDrug
Matching placebo in 1.5ml solution for injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to the first occurrence of 4P-MACETime frame: Time to the first occurrence of 4P-MACE (up to approximately 75 months)
Locations
983 sites in 42 countries. Site status is shown where the registry gives one.
Central Alabama Research
Birmingham, Alabama
UAB St Vincents
Birmingham, Alabama
Eastern Shore Research Institute
Fairhope, Alabama
G and L Research LLC
Foley, Alabama
Longwood Research
Huntsville, Alabama
CB Flock Corporation
Mobile, Alabama
The Center for Clinical Trials
Saraland, Alabama
Synexus
Glendale, Arizona
Lenzmeier Family Practice
Glendale, Arizona
Clinical Research Inst of Arizona
Sun City West, Arizona
Clinical Research Advantage Fiel Family and Sports Med, PC
Tempe, Arizona
Synexus Clinical Research US Inc
Tucson, Arizona
Cardiovascular Res Found
Beverly Hills, California
National Heart Institute
Beverly Hills, California
Alliance Clinical
Canoga Park, California
Inland Psychiatric Medical Group
Chino, California
Valley Clinical Trials Inc
Covina, California
Keck Medical Center USC
Los Angeles, California
Charles R Drew University of Medicine and Science
Los Angeles, California
C for Endo Diabetes and MD
Newhall, California
California Medical Research Associates Inc
Northridge, California
Valley Clinical Trials
Northridge, California
Stanford University Medical Center
Palo Alto, California
Headlands Research Sacramento
Sacramento, California
Cordova Clinical Research
Sacramento, California
University of California San Diego
San Diego, California
Kaiser Permanente San Diego
San Diego, California
Acclaim Clinical Research
San Diego, California
San Diego Cardiac Center
San Diego, California
Encompass Clinical Research
Spring Valley, California
Harbor UCLA Medical Center
Torrance, California
Cardiology Associates Medical Group
Ventura, California
Blue Coast Research Center LLC
Vista, California
Interv Cardiology Med Grp
West Hills, California
South Denver Cardiology Associates PC
Littleton, Colorado
Cardiology Ass of Fairfield County
Stamford, Connecticut
Chase Medical Research LLC
Waterbury, Connecticut
Excel Medical Clinical Trials LLC
Boca Raton, Florida
Nova Clinical Research LLC
Bradenton, Florida
Bay Care Medical Group
Clearwater, Florida
Showing 40 of 983 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.